Safety Feasibility and Effect of TTFields (150 kHz) Concomitant With Gemcitabine or Concomitant With Gemcitabine Plus Nab-paclitaxel for Front-line Therapy of Advanced Pancreatic Adenocarcinoma (PANOVA)

NCT01971281 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DEVICE: NovoTTF-100L
DRUG: Gemcitabine
DRUG: nab-Paclitaxel

Sponsor

NovoCure Ltd.